NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/18/2024
Back to search
Official data from USPTO
ELIMSA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
10/18/2024
Trademark type
Word
Nice classes
5, 9
Filing date
02/18/2021
Registration date
03/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
03/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CA
Examiner
REID, CAILE MAUREEN
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
YYZ Pharmatech, Inc.
Representatives
Nicole K. McLaughlin DUANE MORRIS LLP
Technical classification
Nice Classes
Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic and test kitsdiagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Diagnostic and test kitsdrug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of proteinDNARNAantibodynanobodyaptamerpeptidebiopolymer; Diagnostic and test kitsdiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioninfectious diseasesoncology being cancersneurological diseasesimmunological diseasescardiovascular diseasesgenetic diseasesenvironmental diseasesdietary diseasespathogens; diagnostic reagents for medicinal use; medical diagnostic reagents; Kits for testing of body fluidsmedical diagnostic reagents and assays for testing body fluidstissues or cells for microorganisms; Kits for testing of body fluidsmedical diagnostic reagents and assays for testing of body fluids and tissue of cells for human healthcapture and detection reagents for environmental usehuman healthagriculturefood and nutrition; laboratory and scientific equipment for detectionquantification of analytesbiopolymers or germsdiagnosis of virusdisease and pathogensdiagnostic media for bacteriological culturesmedical diagnostic test media in the form of stripthreadsmulti-well platesmicrobeadsnanobeadsfor measuring pathological conditionphenotypic conditiongenotypic condition; and replacement parts and fittings therefor
Class 9
Laboratory and scientific equipment for diagnostic testing and medical treatmenttest tubesmicroscope slidesincubatorslaboratory robotschromatography supports being chromatography apparatus for laboratory use; Laboratory and scientific equipment for diagnostic testing and medical treatmentdiagnostic apparatus for the detection of pathogens for laboratory or research use; Laboratory and scientific equipment for diagnostic testing and medical treatmentmedical diagnostic simulators for use as teaching aids for detecting pathogensDNA analysischromatography; electrophoresis laboratory apparatus and instruments for extracting biomolecules within enzyme-linked immunosorbent assaysimmunoblotspolymerase chain reactions (PCR)hybridizationbinding assaysnucleic acidsDNARNAproteinsantigensnot for medical purposes; analytical apparatus in the nature of an automated slide stainer for use in medical laboratories; and replacement parts and fittings therefor
Publications
History of USPTO decisions and trademark events.
40 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/12/2023
FIMP
FINAL DISPOSITION PROCESSED
06/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2022
PUBO
PUBLISHED FOR OPPOSITION
12/20/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/30/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2022
ALIE
ASSIGNED TO LIE
11/14/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/09/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/09/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/02/2022
EXPI
EX PARTE APPEAL-INSTITUTED
11/02/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
11/02/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
11/02/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/03/2022
GNFR
FINAL REFUSAL E-MAILED
05/03/2022
CNFR
FINAL REFUSAL WRITTEN
05/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2022
DOCK
ASSIGNED TO EXAMINER
03/09/2022
RFNT
REFUSAL PROCESSED BY IB
10/30/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/05/2021
RFRR
REFUSAL PROCESSED BY MPU
10/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/21/2021
CNRT
NON-FINAL ACTION WRITTEN
09/20/2021
DOCK
ASSIGNED TO EXAMINER
09/14/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2021
Continuous trademark protection
Get notified about every new filing that threatens ELIMSA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.